These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
666 related articles for article (PubMed ID: 11884718)
1. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Xiong JP; Stehle T; Zhang R; Joachimiak A; Frech M; Goodman SL; Arnaout MA Science; 2002 Apr; 296(5565):151-5. PubMed ID: 11884718 [TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the extracellular segment of integrin alpha Vbeta3. Xiong JP; Stehle T; Diefenbach B; Zhang R; Dunker R; Scott DL; Joachimiak A; Goodman SL; Arnaout MA Science; 2001 Oct; 294(5541):339-45. PubMed ID: 11546839 [TBL] [Abstract][Full Text] [Related]
3. Coming to grips with integrin binding to ligands. Arnaout MA; Goodman SL; Xiong JP Curr Opin Cell Biol; 2002 Oct; 14(5):641-51. PubMed ID: 12231361 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, SAR and in vitro evaluation of new cyclic Arg-Gly-Asp pseudopentapeptides containing a s-cis peptide bond as integrin alphavbeta3 and alphavbeta5 ligands. Salvati M; Cordero FM; Pisaneschi F; Melani F; Gratteri P; Cini N; Bottoncetti A; Brandi A Bioorg Med Chem; 2008 Apr; 16(8):4262-71. PubMed ID: 18343671 [TBL] [Abstract][Full Text] [Related]
5. Site-specific inhibition of integrin alpha v beta 3-vitronectin association by a ser-asp-val sequence through an Arg-Gly-Asp-binding site of the integrin. Choi Y; Kim E; Lee Y; Han MH; Kang IC Proteomics; 2010 Jan; 10(1):72-80. PubMed ID: 19882657 [TBL] [Abstract][Full Text] [Related]
6. Divalent cations and the relationship between alphaA and betaA domains in integrins. Seow KT; Xiong JP; Arnaout MA; Welge J; Rippmann F; Goodman SL Biochem Pharmacol; 2002 Sep; 64(5-6):805-12. PubMed ID: 12213573 [TBL] [Abstract][Full Text] [Related]
7. Morpholine-based RGD-cyclopentapeptides as alphavbeta3/alphavbeta5 integrin ligands: role of configuration towards receptor binding affinity. Cini N; Trabocchi A; Menchi G; Bottoncetti A; Raspanti S; Pupi A; Guarna A Bioorg Med Chem; 2009 Feb; 17(4):1542-9. PubMed ID: 19195898 [TBL] [Abstract][Full Text] [Related]
8. Identification of the principal binding site for RGD-containing ligands in the alpha(V)beta(3) integrin: a photoaffinity cross-linking study. Yahalom D; Wittelsberger A; Mierke DF; Rosenblatt M; Alexander JM; Chorev M Biochemistry; 2002 Jul; 41(26):8321-31. PubMed ID: 12081480 [TBL] [Abstract][Full Text] [Related]
9. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands. Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378 [TBL] [Abstract][Full Text] [Related]
10. Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist. Belvisi L; Riccioni T; Marcellini M; Vesci L; Chiarucci I; Efrati D; Potenza D; Scolastico C; Manzoni L; Lombardo K; Stasi MA; Orlandi A; Ciucci A; Nico B; Ribatti D; Giannini G; Presta M; Carminati P; Pisano C Mol Cancer Ther; 2005 Nov; 4(11):1670-80. PubMed ID: 16275988 [TBL] [Abstract][Full Text] [Related]
11. The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site. Fujita M; Takada YK; Takada Y PLoS One; 2014; 9(5):e96372. PubMed ID: 24789099 [TBL] [Abstract][Full Text] [Related]
12. Mapping the integrin alpha V beta 3-ligand interface by photoaffinity cross-linking. Bitan G; Scheibler L; Greenberg Z; Rosenblatt M; Chorev M Biochemistry; 1999 Mar; 38(11):3414-20. PubMed ID: 10079087 [TBL] [Abstract][Full Text] [Related]
13. The α-subunit regulates stability of the metal ion at the ligand-associated metal ion-binding site in β3 integrins. Rui X; Mehrbod M; Van Agthoven JF; Anand S; Xiong JP; Mofrad MRK; Arnaout MA J Biol Chem; 2014 Aug; 289(33):23256-23263. PubMed ID: 24975416 [TBL] [Abstract][Full Text] [Related]
14. Immunosuppressory activity of the cyclodimeric peptide with RGD-sequences. Szewczuk Z; Buczek P; Stefanowicz P; Krajewski K; Wieczorek Z; Siemion IZ Acta Biochim Pol; 2001; 48(1):121-30. PubMed ID: 11440161 [TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of arg-gly-asp ligand specificity for beta3 integrins. Kunicki TJ; Annis DS; Felding-Habermann B J Biol Chem; 1997 Feb; 272(7):4103-7. PubMed ID: 9020120 [TBL] [Abstract][Full Text] [Related]
17. The role of the divalent cation in the structure of the I domain from the CD11a/CD18 integrin. Qu A; Leahy DJ Structure; 1996 Aug; 4(8):931-42. PubMed ID: 8805579 [TBL] [Abstract][Full Text] [Related]
19. Ligand-integrin alpha v beta 3 interaction determined by photoaffinity cross-linking: a challenge to the prevailing model. Bitan G; Scheibler L; Mierke DF; Rosenblatt M; Chorev M Biochemistry; 2000 Sep; 39(36):11014-23. PubMed ID: 10998238 [TBL] [Abstract][Full Text] [Related]